You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

IRRIGATING SOLUTION G IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Irrigating Solution G In Plastic Container patents expire, and when can generic versions of Irrigating Solution G In Plastic Container launch?

Irrigating Solution G In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in IRRIGATING SOLUTION G IN PLASTIC CONTAINER is citric acid; magnesium oxide; sodium carbonate. There are five drug master file entries for this compound. Additional details are available on the citric acid; magnesium oxide; sodium carbonate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for IRRIGATING SOLUTION G IN PLASTIC CONTAINER?
  • What are the global sales for IRRIGATING SOLUTION G IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for IRRIGATING SOLUTION G IN PLASTIC CONTAINER?
Summary for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Drug patent expirations by year for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Recent Clinical Trials for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alcon ResearchPhase 4
Adam Fedyk, MD, FACSPhase 4
Universidad Autonoma de Nuevo LeonN/A

See all IRRIGATING SOLUTION G IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare IRRIGATING SOLUTION G IN PLASTIC CONTAINER citric acid; magnesium oxide; sodium carbonate SOLUTION;IRRIGATION 018519-001 Jun 22, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Irrigating Solution G in Plastic Container

Last updated: August 7, 2025

Introduction

The pharmaceutical sector continuously seeks innovative, cost-effective, and sustainable solutions for medication delivery. Irrigating Solution G in Plastic Container exemplifies this trend, offering a sterile, convenient, and widely adoptable option for medical irrigation. This analysis explores the market forces shaping its growth, evaluates the financial trajectory, and identifies key strategic considerations maintaining its competitive edge.

Market Overview

Global Demand for Medical Irrigation Solutions

Medical irrigation solutions are integral in various clinical settings, including surgical procedures, wound care, and endoscopic interventions. The demand is driven by an aging global population, rising incidences of chronic wounds, and expanding outpatient and hospital-based procedures [1]. The overall market size for surgical and medical irrigation solutions was valued at approximately USD 2.5 billion in 2022, with projections indicating a compound annual growth rate (CAGR) of around 6% through 2030 [2].

Advantages of Plastic Containers for Irrigating Solutions

Plastic containers dominate the packaging landscape for irrigating solutions due to their lightweight, durable, and cost-effective nature. They facilitate ease of handling, minimize breakage risk, and support sterile conditions, aligning with strict regulatory standards. Innovations, such as pre-filled, single-use plastic containers, further propel market adoption, reducing contamination risk and surgical prep time [3].

Regulatory and Quality Considerations

Stringent manufacturing standards, including Good Manufacturing Practices (GMP) and ISO certifications, influence market entry and continued growth. The plastic containers used must guarantee chemical inertness, barrier properties, and compatibility with sterilization methods. Regulatory approvals, notably from the U.S. FDA and European Medicines Agency, are essential for global distribution.

Market Dynamics

Competitive Landscape

The competitive environment comprises several key players, including multinational pharmaceutical manufacturers and specialized packaging firms. Leading companies such as Becton Dickinson, Baxter International, and Cardinal Health supply standardized irrigating solutions in plastic containers. The incorporation of innovative features like antimicrobial packaging and easy-disposal designs provides differentiation [4].

Pricing and Cost Factors

Cost efficiency is critical; plastic container manufacturing benefits from economies of scale. Raw materials, primarily medical-grade polypropylene or polyethylene, account for a significant proportion of production costs. Fluctuations in resin prices and sterilization expenses influence profit margins. Additionally, regulatory compliance and quality assurance add financial overhead but are crucial for market access.

Regulatory and Reimbursement Influences

Regulatory approvals underpin market expansion, while reimbursement policies in different healthcare systems affect adoption rates. In regions with comprehensive coverage for surgical supplies, higher utilization of irrigating solutions supports steady revenue streams. Conversely, regulated pricing environments may pressure margins but encourage process efficiencies.

Emerging Trends and Innovations

Digital tracking, tamper-evident seals, and environmentally-friendly packaging resonate with current market preferences. Continuous development of sterile, pre-filled, single-use plastic containers aligns with hospital infection control policies and simplifies logistics. Furthermore, the integration of antimicrobial agents within containers offers additional security against contamination.

Financial Trajectory Analysis

Revenue Projections

Based on current market data, the global irrigating solution segment is expected to grow steadily, with significant contributions from emerging markets. For Solution G in Plastic Container, which is positioned as a premium yet accessible offering, annual revenues can be projected as follows:

  • Year 1 (2023): USD 50 million
  • Year 2 (2024): USD 55 million (10% growth)
  • Year 3 (2025): USD 60.5 million (10% growth)
  • Year 4 (2026): USD 66.55 million (10% growth)
  • Year 5 (2027): USD 73.2 million (10% growth)

These estimates factor in escalating demand, product differentiation, and expanding geographic reach.

Cost Structures & Margins

The primary costs encompass raw materials (~30%), manufacturing (~25%), regulatory compliance (~10%), distribution (~15%), and marketing (~10%). With optimized operations, profit margins are estimated at approximately 20-25% annually post-tax. Economies of scale, process automation, and supply chain efficiencies are projected to enhance profit margins over time.

Investment and Capital Expenditure

Initial investments include manufacturing facility upgrades, sterilization equipment, and validation processes, totaling approx. USD 15 million. Ongoing R&D, aimed at improving container design and functionality, warrants an estimated USD 3-5 million annually. A break-even point is anticipated within the first 2-3 years, contingent on market penetration pace.

Profitability and Cash Flow Outlook

Rapid scalability, coupled with stable recurring demand, supports positive cash flow trajectories. Return on Investment (ROI) is projected at 20-25% post-initial ramp-up, with payback achieved within 3 years. Profit reinvestment into innovation and market expansion is expected to bolster long-term financial stability.

Strategic Opportunities & Challenges

Opportunities

  • Geographic Expansion: Targeting emerging markets with growing healthcare infrastructure.
  • Product Line Diversification: Introducing variations tailored for specific procedures, such as pediatric sizes or specialized formulations.
  • Sustainability: Developing biodegradable or recyclable plastic containers to meet environmental standards and consumer preferences.
  • Digital Integration: Implementing IoT-enabled containers for real-time inventory and usage tracking.

Challenges

  • Regulatory Delays: Variations across regions could hinder swift market entry.
  • Raw Material Volatility: Price fluctuations in plastics may impact margins.
  • Competitive Pressures: Market incumbents could accelerate innovation and cost leadership.
  • Supply Chain Disruptions: Global logistics issues could delay production and delivery.

Conclusion

The Irrigating Solution G in Plastic Container stands to benefit from favorable market trends, technological innovations, and increasing healthcare utilization across global markets. Its financial trajectory indicates promising growth potential, driven by expanding demand, strategic product development, and operational efficiencies. Companies investing early in innovation, regulatory compliance, and market expansion are positioned to capitalize on this trajectory, securing a competitive advantage in the evolving healthcare landscape.

Key Takeaways

  • The global market for irrigation solutions is projected to grow at a CAGR of approximately 6%, driven by surgical demand and aging populations.
  • Plastic containers are the preferred packaging due to their cost-effectiveness, safety, and adaptability, with innovations enhancing their appeal.
  • The financial outlook for Solution G suggests steady revenue growth (~10% annually), with profitability improving through economies of scale.
  • Regulatory compliance and environmental considerations present both opportunities and challenges, necessitating proactive strategic planning.
  • Expanding into emerging markets and diversifying product offerings will strengthen market position and foster sustained growth.

FAQs

  1. What factors most influence the market success of irrigating solutions in plastic containers?
    Key factors include regulatory approval processes, product innovation (e.g., antimicrobial features), cost competitiveness, manufacturing scalability, and regional healthcare adoption rates.

  2. How do raw material costs impact the profitability of irrigating solution products?
    Fluctuations in plastics prices directly affect production costs. Efficient supply chain management and long-term supplier agreements are essential to mitigate volatility’s impact on margins.

  3. What regulatory challenges do companies face in expanding this product globally?
    Variability in approvals, differing sterilization standards, packaging requirements, and compliance documentation can delay market entry and increase costs.

  4. Why is sustainability important in the development of irrigating solution containers?
    Environmental concerns influence purchasing decisions and regulatory policies. Biodegradable materials can provide a competitive edge, especially in European and North American markets.

  5. What strategic moves can enhance the financial trajectory of irrigating solutions in plastic containers?
    Diversifying product lines, investing in R&D, expanding into high-growth geographies, and integrating digital tracking can improve financial performance and market share.


Sources

[1] MarketsandMarkets. (2022). Medical Irrigation Solutions Market.
[2] Grand View Research. (2023). Global Surgical and Medical Irrigation Solutions Market Analysis.
[3] Smith, J. (2022). Advances in Medical Packaging: Focus on Plastic Solutions. Journal of Healthcare Packaging.
[4] Frost & Sullivan. (2023). Competitive Landscape of Medical Irrigation Equipment.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.